Skip to main content

Linden Thomas Advisory Services, LLC

Position in NBIX — Neurocrine Biosciences Inc

CIK 1965702 Charlotte, NC

Position in NBIX

as of Jun 30, 2026 · filed Jul 16, 2026
Position Value
$3,147,653
+$2,164,741 QoQ
Shares Held
18,676
+150.3% QoQ
Ownership
0.018%
of shares outstanding
% of Portfolio
0.26%
of 13F equity value
Holder Rank
#256
of 768 holders
Holding Since
Dec 2022
15 quarters on record
Voting authority Sole 0% Shared 0% None 100%

Common Shares in NBIX Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Jun 30, 2026

Linden Thomas Advisory Services, LLC holds $9,701,809 across 5 Drug Manufacturers - Specialty & Generic names. NBIX ranks #2 (32.4% of the industry book) .

# Ticker Company Shares Value (USD) Open
2 NBIX
Neurocrine Biosciences Inc
This page
18,676 $3,147,653

All Filings in NBIX

Export CSV
15 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $3,147,653 18,676
2026-03-31 $982,912 7,461
2025-12-31 $966,004 6,811
2025-09-30 $960,901 6,845
2025-06-30 $841,997 6,699
2025-03-31 $730,291 6,603
2024-12-31 $866,775 6,350
2024-09-30 $698,348 6,061
2024-06-30 $797,935 5,796
2024-03-31 $933,442 6,768
2023-12-31 $850,642 6,456
2023-09-30 $700,987 6,231
2023-06-30 $1,464,761 15,533
2023-03-31 $1,558,281 15,395
2022-12-31 $1,794,466 15,024